DUBLIN--(BUSINESS WIRE)--The "Global Macular Edema Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering. Macular Edema Pipeline Highlights - 2019 ...
OCS-01’s positive results in Stage 1 of the Phase 3 DIAMOND trial for diabetic macular edema (DME) were presented as a late-breaking abstract showing that the trial met primary and secondary endpoints ...
DUBLIN--(BUSINESS WIRE)--The "Macular Edema - Pipeline Review, H1 2018" report has been added to ResearchAndMarkets.com's offering. Macular Edema - Pipeline Review, H1 2018, provides comprehensive ...
DIAMOND trial in Diabetic Macular Edema (DME) with topical OCS-01 met its stage 1 objective of validating the loading and maintenance dosing regimen designed to optimize OCS-01 efficacy potential with ...